Search research articles
Contact Us
Filters
Showing results (41-50 of 140) with videos related to
Page
of 14
Sort By:
Journal of Translational Medicine
|
January 15, 2016
Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial
Raya Leibowitz-Amit, Melania Pintilie, Leila Khoja, et al.
Investigational New Drugs
|
March 28, 2014
A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer
Arun A Azad, Emma K Beardsley, Sebastian J Hotte, et al.
European Urology
|
March 12, 2025
T-cell Engagers in Prostate Cancer
Chadi Hage Chehade, Zeynep Irem Ozay, Micah Ostrowski, et al.
Future Oncology (London, England)
|
October 25, 2024
The TALAPRO-3 study design: a plain language summary
Neeraj Agarwal, Fred Saad, Arun A Azad, et al.
Internal Medicine Journal
|
March 12, 2021
Predictors of real-world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer
Arun A Azad, Ben Tran, Ian D Davis, et al.
Cell Reports. Medicine
|
August 21, 2024
HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES
Nima Sharifi, Arun A Azad, Mona Patel, et al.
Future Oncology (London, England)
|
April 14, 2026
Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01
Arun A Azad, Neeraj Agarwal, Andrew J Armstrong, et al.
Future Oncology (London, England)
|
October 26, 2023
TALAPRO-3 clinical trial protocol: phase III study of talazoparib plus enzalutamide in metastatic castration-sensitive prostate cancer
Neeraj Agarwal, Fred Saad, Arun A Azad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2026
Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide
Andrew J Armstrong, Arun A Azad, Taro Iguchi, et al.
BJU International
|
April 14, 2026
From salvage to spotlight: how 2025 transformed PSMA radioligand therapy
Abdullah Al-Khanaty, Carlos Delgado, Francisco Valencia, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 140) with videos related to
Sort By:
Page
of 14
Journal of Translational Medicine
|
January 15, 2016
Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial
Raya Leibowitz-Amit, Melania Pintilie, Leila Khoja, et al.
Investigational New Drugs
|
March 28, 2014
A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer
Arun A Azad, Emma K Beardsley, Sebastian J Hotte, et al.
European Urology
|
March 12, 2025
T-cell Engagers in Prostate Cancer
Chadi Hage Chehade, Zeynep Irem Ozay, Micah Ostrowski, et al.
Future Oncology (London, England)
|
October 25, 2024
The TALAPRO-3 study design: a plain language summary
Neeraj Agarwal, Fred Saad, Arun A Azad, et al.
Internal Medicine Journal
|
March 12, 2021
Predictors of real-world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer
Arun A Azad, Ben Tran, Ian D Davis, et al.
Cell Reports. Medicine
|
August 21, 2024
HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES
Nima Sharifi, Arun A Azad, Mona Patel, et al.
Future Oncology (London, England)
|
April 14, 2026
Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01
Arun A Azad, Neeraj Agarwal, Andrew J Armstrong, et al.
Future Oncology (London, England)
|
October 26, 2023
TALAPRO-3 clinical trial protocol: phase III study of talazoparib plus enzalutamide in metastatic castration-sensitive prostate cancer
Neeraj Agarwal, Fred Saad, Arun A Azad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2026
Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide
Andrew J Armstrong, Arun A Azad, Taro Iguchi, et al.
BJU International
|
April 14, 2026
From salvage to spotlight: how 2025 transformed PSMA radioligand therapy
Abdullah Al-Khanaty, Carlos Delgado, Francisco Valencia, et al.
Page
of 14